Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
Per Eystein Lønning(Haukeland University Hospital), Giorgio Massimini(Haukeland University Hospital), E. Di Salle(Peter MacCallum Cancer Centre), E. Mickiewicz(University of Chicago), Luigi Celio, Paula Pitt(Peter MacCallum Cancer Centre), Emilio Bajetta(Fondazione Lanza), Camilla Fowst(Inserm), Anna Polli(Pfizer (Italy)), Neil K. Aaronson(The Netherlands Cancer Institute), Alexei Arkhipov(Peter MacCallum Cancer Centre), Monica Mita(Novartis (Switzerland)), M. Tubiana-Hulin(Heidelberg University), Peter D. Eisenberg(Princess Margaret Cancer Centre), Robin Murray(South London and Maudsley NHS Foundation Trust)
Cited by 318
Related Papers
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k